Tag: Polar Capital
Pfizer keeping tabs on AstraZeneca for potential $100 billion deal
US drug-maker Pfizer Inc has prepared a third offer to acquire Britain's AstraZeneca Plc, after refusing Pfizer’s earlier approaches for a takeover.
According to the...
Featured Article
Responding to manufacturing demand and performance signals
Australian manufacturers are navigating a challenging environment. Just as output had returned to growth, higher fuel and freight costs, rising input prices and global supply chain disruption renewed pressure on margins and cash flow.
